SSR182289A, a selective and potent orally active thrombin inhibitorJ.M. Altenburger, Jean‐Marc Herbert, Gilbert Lassalle et al.|Bioorganic & Medicinal Chemistry|2004Cited by 133
5-Chlorothiophene-2-carboxylic Acid [(<i>S</i>)-2-[2-Methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a Selective and Potent Orally Active Dual Thrombin and Factor Xa InhibitorJérôme Meneyrol, Jean‐Marc Herbert, Markus Follmann et al.|Journal of Medicinal Chemistry|2013Cited by 25
Potential Therapeutic Value of Urotensin II Receptor Antagonist in Chronic Kidney Disease and Associated ComorbiditiesMarie‐Laure Ozoux, Philip Janiak, Véronique Briand et al.|Journal of Pharmacology and Experimental Therapeutics|2020Cited by 16
Factor Xa in complex with the dual thrombin-FXa inhibitor 57.Jérôme Meneyrol, J. M. Herbert, Markus Follmann et al.|Unknown|2013Cited by 0
factor Xa in complex with the dual thrombin-FXa inhibitor 31.Jérôme Meneyrol, J. M. Herbert, Markus Follmann et al.|Unknown|2013Cited by 0